Analysis of CD177 neutrophil expression in β-thalassemia patients

APMIS

Volumn 119, Issue 10, 2011, Pages 674-680

  Montaser, Laila Mahmoud ^a   El Rashidi, Farida Hussein ^a   Essa, Enas Said ^a   Azab, Samar Mostafa ^b  

^a MENOUFIA UNIVERSITY   (Egypt)

^b Shebein ElKom Educational Hospital   (Egypt)

Author keywords

thalassemia; CD177; Flow cytometry

Indexed keywords

ANTIGEN; BIOLOGICAL MARKER; CD177 ANTIGEN; TRANSFERRIN RECEPTOR; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; BETA THALASSEMIA; BETA THALASSEMIA INTERMEDIA; BETA THALASSEMIA MAJOR; CELLULAR PARAMETERS; CHILD; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME IMMUNOASSAY; ERYTHROPOIESIS; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; NEUTROPHIL; NEUTROPHIL MEAN FLUORESCENCE INTENSITY RATIO; POLYCYTHEMIA VERA; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SEX DIFFERENCE;

ADOLESCENT; BETA-THALASSEMIA; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; ERYTHROPOIESIS; FEMALE; FLOW CYTOMETRY; GPI-LINKED PROTEINS; HUMANS; IMMUNOENZYME TECHNIQUES; INFANT; ISOANTIGENS; MALE; NEUTROPHILS; RECEPTORS, CELL SURFACE; RECEPTORS, TRANSFERRIN; STATISTICS, NONPARAMETRIC;

EID: 80052830814     PISSN: 09034641     EISSN: 16000463     Source Type: Journal    
DOI: 10.1111/j.1600-0463.2011.02755.x     Document Type: Article

References (27)

1. Olivieri NF, Weatherall DJ. Clinical Aspects of β-Thalassemia and Related Disorders. In: Steinberg MH, Forget BG, Higgs DR, Weatherall DJ, editors. Disorders of Hemoglobin; Genetics, Pathophysiology and Clinical Management, 2nd edn. Cambridge: Cambridge University Press, 2001: 357-417.
2. Stroncek DF, Caruccio L, Bettinotti M. CD177: a member of the Ly-6 gene superfamily involved with neutrophil proliferation and polycythemia vera. J Transl Med 2004;2:8.
3. Lalezari P, Murphy GB, Allen FH. NB1, a new neutrophil-specific antigen involved in the pathogenesis of neonatal neutropenia. J Clin Invest 1971;50:1108-15.
4. ISBT Working Party on Platelet and Granulocyte Serology. Nomenclature of granulocyte antigens. Vox Sang 1999;77:251.
5. Mason DY, André P, Bensussan A, Buckley C, Civin C, Clark E, et al. CD antigens. Tissue Antigens 2001;58:425-30.
6. Stroncek DF. Neutrophil-specific antigen HNA-2a, NB1 glycoprotein, and CD177. Curr Opin Hematol 2007;14:688-93.
7. Temerinac S, Klippel S, Strunck E, Röder S, Lübbert M, Lange W, et al. Cloning of PRV-1, a novel member of the uPAR receptor superfamily, which is overexpressed in polycythaemia rubra vera. Blood 2000;95:2569-76.
8. Zoi K, Terpos E, Zoi C, Loukopoulos D. Increased CD177 (PRV1) expression in thalassemia and the underlying erythropoietic activity. Br J Haematol 2008;141:100-4.
9. Beguin Y. Soluble transferrin receptor for the evaluation of erythropoiesis and iron status. Clin Chim Acta 2003;329:9-22.
10. Jayaranee S, Sthaneshwar P. Serum soluble transferrin receptor in hypochromic microcytic anaemia. Singapore Med J 2006;47:138-42.
11. Matsuo K, Lin A, Procter JL, Clement L, Stroncek D. Variations in the expression of granulocyte antigen NB1. Transfusion 2000;40:654-62.
12. Wenger RH. Mammalian oxygen sensing, signalling and gene regulation. J Exp Biol 2000;203:1253-63.
13. Maxwell PH, Pugh CW, Ratcliffe PJ. Inducible operation of the erythropoietin 3' enhancer in multiple cell lines: evidence for a widespread oxygen-sensing mechanism. Proc Natl Acad Sci USA 1993;90:2423-7.
14. Jelkmann W. Molecular biology of erythropoietin. Intern Med 2004;43:649-59.
15. Walmsley SR, Print C, Farahi N, Peyssonnaux C, Johnson RS, Cramer T, et al. Hypoxia-induced neutrophil survival is mediated by HIF-1alpha-dependent NF-kappaB activity. J Exp Med 2005;201:105-15.
16. Huebers HA, Beguin Y, Pootrakul P, Einspahr D, Finch CA. Intact transferrin receptors in human plasma and their relation to erythropoiesis. Blood 1990;75:102-7.
17. Camaschella C, Gonella S, Calabrese R, Vischia F, Roetto A, Graziadei G, et al. Serum erythropoietin and circulating transferrin receptor in thalassemia intermedia patients with heterogeneous genotypes. Haematologica 1996;81:397-403.
18. El-Nawawy A, Massoud MN, El-Bordiny M, Hegazya S. Evaluation of serum soluble transferrin receptors and erythropoietin levels as indicators for erythropoietic activity among multi-transfused beta-thalassemic patients. J Trop Pediatr 2002;48:33-8.
19. Kossiva L, Paterakis G, Tassiopoulos S, Papadhimitriou SI, Voukouti E, Gligori I, et al. Decreased expression of membrane alpha4beta1, alpha5beta1 integrins and transferrin receptor on erythroblasts in splenectomized patients with beta-thalassemia intermedia. Parallel assessment of serum soluble transferrin receptors levels. Ann Hematol 2003;82:579-84.
20. Cazzola M, De Stefano P, Ponchio L, Locatelli F, Beguin Y, Dessi C, et al. Relationship between transferrin regimen and suppression of erythropoiesis in beta-thalassemia major. Br J Haematol 1995;89:473-8.
21. Tancabelic J, Sheth S, Paik M, Piomelli S. Serum transferrin receptor as a marker of erythropoiesis suppression in patients on chronic transfusion. Am J Hematol 1999;60:121-5.
22. R'zik S, Beguin Y. Serum soluble transferrin receptor concentration is an accurate estimate of the mass of tissue receptors. Exp Hematol 2001;29:677-85.
23. Scott MD. Intra-erythrocytic iron chelation: a new therapy for thalassemia? Hematology 2001;6:73-89.
24. Taniguchi K, Kobayashi M, Harada H, Hiraoka A, Tanihiro M, Takata N, et al. Human neutrophil antigen-2a expression on neutrophils from healthy adults in western Japan. Transfusion 2002;42:651-7.
25. Caruccio L, Bettinotti M, Matsuo K, Sharon V, Stroncek D. Expression of neutrophil-specific antigen HNA-2a (NB1) is increased in pregnancy. Transfusion 2003;43:357-63.
26. Lin M, Chen CC, Wang CL, Lee HL. Frequencies of neutrophil-specific antigens among Chinese in Taiwan. Vox Sang 1994;66:247.
27. Bierling P, Poulet E, Fromont P, Seror T, Bracq C, Duedari N. Neutrophil-specific antigen and gene frequencies in the French population. Transfusion 1990;30:848-9.